A Cost-Utility Analysis of First-Line Treatment in Neuropathic Pain- Pregabalin Versus Venlafaxine
May 1, 2016, 00:00
10.1016/j.jval.2016.03.203
https://www.valueinhealthjournal.com/article/S1098-3015(16)00271-0/fulltext
Title :
A Cost-Utility Analysis of First-Line Treatment in Neuropathic Pain- Pregabalin Versus Venlafaxine
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00271-0&doi=10.1016/j.jval.2016.03.203
First page :
A63
Section Title :
Neurological Disorders - Cost Studies
Open access? :
No
Section Order :
1538